Friday,10 Jan 2025
Bahrain approves Covaxin for emergency use
New Delhi
12-November-2021
The National Health Regulatory Authority (NHRA) of Bahrain on Friday approved Covaxin, India's first indigenous vaccine against Covid-19, for emergency use.
People travelling from India to Bahrain with vaccine certificate issued in India approved by the WHO will be exempted from the 10-day mandatory quarantine and a pre-arrival negative RT-PCR report.
In a statement, the NHRA said that the decision follows the careful evaluation of data provided Bharat Biotech carried out by the Authority's Clinical Trials Committee and Bahrain's Ministry of Health's Immunization Committee.
More than 26,000 people participated in the vaccine's clinical trials, which established that the two-dose regimen jab is 77.8 per cent effective against Covid-19, and 93.4 per cent effective against severe cases of the virus.
The safety data indicated a low incidence of adverse effects, added the NHRA.
Recently, the World Health Organization granted emergency use listing to the Covaxin enabling countries to expedite their regulatory approval to import and administer doses.-IANS
More Headlines
Cold Wave Grips Rajasthan: Fatehpur Hits 1.1°C, Nagaur 1.7°C
Actor Ajith Kumar Escapes Unharmed After Crash During 24H Dubai Practice
32 Dead As 7.1 Magnitude Earthquake Strikes Nepal-Tibet Border
Human Metapneumovirus Cases in India Rise to 5, Former WHO Expert Urges Calm
Oyo Hotels Tighten Rules on Couple Check-Ins to Ensure 'Safe Hospitality'
Cold Wave Grips Rajasthan: Fatehpur Hits 1.1°C, Nagaur 1.7°C
Actor Ajith Kumar Escapes Unharmed After Crash During 24H Dubai Practice
32 Dead As 7.1 Magnitude Earthquake Strikes Nepal-Tibet Border
Human Metapneumovirus Cases in India Rise to 5, Former WHO Expert Urges Calm
Oyo Hotels Tighten Rules on Couple Check-Ins to Ensure 'Safe Hospitality'